{"version":"1.0","type":"link","title":"ELOVL4 is a Prognostic Biomarker with Implications for Immune Modulation and Therapeutic Response in Gastric Cancer.","author_name":"Chu Y 외","author_url":"https://prs-insight.online/author/Chu%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/124159","thumbnail_width":1200,"thumbnail_height":630}